Honghui Hu of Wanhuida Intellectual Property considers the impact of the structure-activity relationship on the inventiveness assessment of pharmaceutical compounds Bayer Intellectual Property GmbH ...
Assessing a drug compound by its activity, not simply its structure, is a new approach that could speed the search for COVID-19 therapies and reveal more potential therapies for other diseases. This ...
A method has been discovered to easily predict the structure of materials using intuitive information such as the electrical properties or size of atoms without complex computational calculations. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback